Related Experiment Video
Updated: Sep 11, 2025

06:11
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.9K
Multidisciplinary Clinical Quality Indicators for Head and Neck Cancer: A Modified Delphi Study in Australia.
Rebecca L Venchiarutti1,2, Ashleigh R Sharman1, Candice Donnelly2
1Head and Neck Research, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.
ANZ Journal of Surgery
|August 15, 2025
Summary
A priority set of 24 quality indicators (QIs) for head and neck cancer (HNC) care was developed. These indicators will benchmark HNC management and outcomes in Australia.
Area of Science:
- Oncology
- Health Services Research
- Quality Improvement
Background:
- Monitoring cancer care is crucial for improving patient outcomes, especially in resource-limited environments.
- Head and neck cancer (HNC) care quality requires standardized benchmarking and monitoring.
- Developing quality indicators (QIs) is essential for assessing and improving HNC care.
Purpose of the Study:
- To develop a priority set of multidisciplinary quality indicators (QIs).
- To establish a benchmark for monitoring the quality of head and neck cancer (HNC) care in Australia.
Main Methods:
- A systematic literature review identified 317 unique QIs.
- A modified Delphi consensus process involving health professionals and patients with lived experience was conducted over three rounds.
- Consensus on QIs was defined by a mean importance score of ≥6 (out of 7) and at least 75% of participants rating them as 6 or 7.
Main Results:
- The systematic review identified 317 unique QIs, with 81 selected for Delphi Round 2.
- In Round 2, 48 QIs reached consensus among 66 health professionals and 12 patients.
- In Round 3, 24 QIs achieved consensus among 42 health professionals and 10 patients, with most related to treatment commencement and surgical margin documentation.
Conclusions:
- A priority set of 24 clinically relevant QIs for head and neck cancer (HNC) has been developed.
- These QIs will be evaluated in a clinical quality registry.
- The registry aims to benchmark optimal HNC management and patient outcomes.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
Standards of Care II
725
Nurses bear specific legal responsibilities under several federal statutes, including:
725

